Evidence map›Paper›PMID 29320423›Full record

ArticleMolecules (Basel, Switzerland)2018

New Thiazoline-Tetralin Derivatives and Biological Activity Evaluation.

Gülhan Turan-Zitouni, Leyla Yurttaş, Aouatef Tabbi, Gülşen Akalın Çiftçi, Halide Edip Temel, Zafer Asım Kaplancıklı

Abstract readEvaluation Study
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gülhan Turan-ZitouniDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey. gturan@anadolu.edu.tr.
Leyla YurttaşDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey. lyurttas@anadolu.edu.tr.
Aouatef TabbiDepartment of Chemistry, Faculty of Sciences, Mentouri University, 25000 Constantin, Algeria. awateftabbi@yahoo.fr.
Gülşen Akalın ÇiftçiDepartment of Biochemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey.
Halide Edip TemelDepartment of Biochemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey. heincedal@anadolu.edu.tr.
Zafer Asım KaplancıklıDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey. zakaplan@anadolu.edu.tr.ORCID 0000-0003-2252-0923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, novel

Indexed as

A549 CellsAnimalsAntineoplastic AgentsApoptosisCell SurvivalCholinesterase InhibitorsCisplatinDrug Screening Assays, AntitumorHumansHydrazinesMagnetic Resonance SpectroscopyMass SpectrometryMCF-7 CellsMiceMolecular StructureNIH 3T3 CellsAntineoplastic AgentsCholinesterase InhibitorsCisplatinHydrazinesNucleic Acid Synthesis InhibitorsTriazolesanticholinesterase activityapoptosiscytotoxicityDNA synthesis inhibitiontetralin (tetrahydronaftalene)thiazoline

Identifiers

PMID29320423
PMCPMC6017121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.